PuSH - Publikationsserver des Helmholtz Zentrums München

144 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Rubey, M. et al.: DLL1- and DLL4-mediated Notch signaling is essential for adult pancreatic islet homeostasis. Diabetes 69, 915-926 (2020)
22.
Rutter, G.A.* ; Ninov, N. ; Salem, V.* & Hodson, D.J.*: Comment on Satin et al. "Take Me To Your Leader": An electrophysiological appraisal of the role of Hhb cells in pancreatic islets. Diabetes 2020;69:830-836. Diabetes 69, E10-E11 (2020)
23.
Yaghootkar, H.* et al.: Genetic studies of leptin concentrations implicate leptin in the regulation of early adiposity. Diabetes 69, 2806-2818 (2020)
24.
Graae, A.S.* et al.: ADAMTS9 regulates skeletal muscle insulin sensitivity through extracellular matrix alterations. Diabetes 68, 502-514 (2019)
25.
Groener, J.B.* et al.: Understanding diabetic neuropathy: From subclinical nerve lesions to severe nerve fiber deficits. A cross-sectional study in patients with type 2 diabetes and healthy controls. Diabetes 69, 436-447 (2019)
26.
Herrera Moro Chao, D.* et al.: The iminosugar AMP-DNM improves satiety and activates brown adipose tissue through GLP1. Diabetes 68, 2223-2234 (2019)
27.
Hippich, M. et al.: Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes 68, 847-857 (2019)
28.
Ji, Y.* et al.: Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 68, 207-219 (2019)
29.
Ma, J.* et al.: A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for non-alcoholic fatty liver disease. Diabetes 68, 1073-1083 (2019)
30.
Ratner, C.* et al.: Long-acting neurotensin synergizes with liraglutide to reverse obesity through a melanocortin-dependent pathway. Diabetes 68, 1329-1340 (2019)
31.
Wittenbecher, C.* et al.: Insulin-like growth factor binding protein 2 (IGFBP-2) and the risk of developing type 2 diabetes. Diabetes 68, 188-197 (2019)
32.
Endesfelder, D. et al.: Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119-130 (2018)
33.
Herder, C.* et al.: A systemic inflammatory signature reflecting crosstalk between innate and adaptive immunity is associated with polyneuropathy: KORA F4/FF4 Study. Diabetes 67, 2434-2442 (2018)
34.
Kim, T.* et al.: Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21. Diabetes 67, 1773-1782 (2018)
35.
Kroeger, J.* et al.: Circulating fetuin - A and risk of type 2 diabetes : A mendelian randomization analysis. Diabetes 67, 1200-1205 (2018)
36.
Maczewsky, J.* et al.: TGR5 activation promotes stimulus-secretion coupling of pancreatic -cells via a PKA-dependent pathway. Diabetes 67, 324-336:db180315 (2018)
37.
Mueller, K.M.* et al.: Erratum. Adipocyte glucocorticoid Receptor deficiency attenuates aging- and HFD-induced obesity and impairs the feeding-fasting transition. Diabetes 2017;66:272-286. Diabetes 67, 343-344 (2018)
38.
Norris, J.M.* et al.: Plasma 25-hydroxyvitamin D concentration and risk of islet autoimmunity. Diabetes 67, 146-154 (2018)
39.
Pfuhlmann, K. et al.: Celastrol-induced weight loss is driven by hypophagia and independent from UCP1. Diabetes 67, 2456-2465 (2018)
40.
Salami, F.* et al.: Reduction in white blood cell, neutrophil, and red blood cell counts related to sex, HLA, and islet autoantibodies in Swedish TEDDY children at increased risk for type 1 diabetes. Diabetes 67, 2329-2336 (2018)